These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18034948)

  • 1. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis.
    Cheng SL; Wang HC; Yang PC
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1290-5. PubMed ID: 18034948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
    Breen RA; Smith CJ; Bettinson H; Dart S; Bannister B; Johnson MA; Lipman MC
    Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
    Burman W; Weis S; Vernon A; Khan A; Benator D; Jones B; Silva C; King B; LaHart C; Mangura B; Weiner M; El-Sadr W
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1282-9. PubMed ID: 18229435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients.
    Cheng VC; Ho PL; Lee RA; Chan KS; Chan KK; Woo PC; Lau SK; Yuen KY
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):803-9. PubMed ID: 12461590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical response in HIV-negative patients with pleural tuberculosis: a retrospective multicentre study.
    Jeon K; Choi WI; An JS; Lim SY; Kim WJ; Park GM; Park SS; Choi HS; Lee BH; Choi JC; Na MJ; Park J; Kim JY
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):846-51. PubMed ID: 22507441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis.
    Cho OH; Park KH; Kim T; Song EH; Jang EY; Lee EJ; Chong YP; Choi SH; Lee SO; Woo JH; Kim YS; Kim SH
    J Infect; 2009 Jul; 59(1):56-61. PubMed ID: 19535147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study.
    Uppal SS; Tewari SC; Verma S; Dhot PS
    Cytometry B Clin Cytom; 2004 Sep; 61(1):20-6. PubMed ID: 15351978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of 23 cases of AIDS complicated by tuberculosis].
    Yuan J; Yu WY; Hu YW; Jiang XL; Luo ZY; Wen B; Liu Y; Wu M
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):767-70. PubMed ID: 15634391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.
    Jakubowiak WM; Bogorodskaya EM; Borisov SE; Danilova ID; Kourbatova EV
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):46-53. PubMed ID: 17217129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in southern Chinese renal-transplant recipients.
    Chen SY; Wang CX; Chen LZ; Fei JG; Deng SX; Qiu J; Li J; Chen GO; Fu HM; Xie CM
    Clin Transplant; 2008; 22(6):780-4. PubMed ID: 19040560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi.
    Yu JK; Bong CN; Chen SC; Dzimadzi R; Lu DY; Makombe SD; Schouten EJ; Kamoto K; Harries AD
    Int J Tuberc Lung Dis; 2008 Jun; 12(6):692-4. PubMed ID: 18492340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical reaction during tuberculosis treatment in immunocompetent children: clinical spectrum and risk factors.
    Olive C; Mouchet F; Toppet V; Haelterman E; Levy J
    Pediatr Infect Dis J; 2013 May; 32(5):446-9. PubMed ID: 23271443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.
    Alisjahbana B; Sahiratmadja E; Nelwan EJ; Purwa AM; Ahmad Y; Ottenhoff TH; Nelwan RH; Parwati I; van der Meer JW; van Crevel R
    Clin Infect Dis; 2007 Aug; 45(4):428-35. PubMed ID: 17638189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment.
    Roussos A; Lagogianni I; Gonis A; Ilias I; Kazi D; Patsopoulos D; Philippou N
    Respir Med; 2001 Mar; 95(3):187-90. PubMed ID: 11266235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis infection in renal transplant recipients.
    Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
    Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitubercular drug treatment failure and HIV infection in Abidjan (Ivory Coast)].
    Daix T; Domoua K; Coulibaly G; Kissi H; Beugre-Sy L; Yapi A
    Bull Soc Pathol Exot; 2003 Mar; 96(1):39-40. PubMed ID: 12784592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors.
    Sterling TR; Zhao Z; Khan A; Chaisson RE; Schluger N; Mangura B; Weiner M; Vernon A;
    Int J Tuberc Lung Dis; 2006 May; 10(5):542-9. PubMed ID: 16704037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.